Ebola: experimental drug cures monkeys infected with the virus
Scientists developing TKM-Ebola celebrate successful animal trial as the race for a human cure continues
Scientists have used an experimental drug to successfully treat monkeys with Ebola, raising hopes of a human cure.
"This is the first study to show post-exposure protection," senior author Thomas Geisbert told the BBC.
TKM-Ebola-Guinea targets the Makona strain of the virus which is responsible for the ongoing outbreak in West Africa that has left over 10,000 people dead.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Developed by a Canadian pharmaceutical company, the drug works by interfering with the virus's genetic code, stopping it from producing disease-causing proteins.
One of the main advantages of the drug is that it can be easily modified to target different strains of virus. It is also be relatively quickly manufactured, while alternative drugs – such as the experimental ZMapp – take several months to produce.
During the animal trial, six monkeys were given a lethal dose of the virus. Three days later, half were given the drug while the other half were left untreated. All of the animals who received TKM Ebola went on to make a full recovery, while the others three died within nine days.
Geisbert said his team were hopeful that the results could be replicated in humans. "In most cases we would say there is a 90 per cent chance that this would work but not 100 per cent – there's nothing that is that definitive," he told the Daily Telegraph.
A number of Ebola patients received the experimental drug during the outbreak, but as they were given several other treatments it is impossible to identify which one was responsible for their recovery.
A large-scale human trial of the drug has already begun in Sierra Leone, but its safety and efficacy are still unknown, with results only expected to be released later this year.
The Ebola outbreak in West Africa is waning, but the World Health Organization continues to warn against complacency, and the race to develop a cure is ongoing.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
'Horror stories of women having to carry nonviable fetuses'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Haiti interim council, prime minister sworn in
Speed Read Prime Minister Ariel Henry resigns amid surging gang violence
By Peter Weber, The Week US Published
-
Today's political cartoons - April 26, 2024
Cartoons Friday's cartoons - teleprompter troubles, presidential immunity, and more
By The Week US Published
-
Nigeria's worsening rate of maternal mortality
Under the radar Economic crisis is making hospitals unaffordable, with women increasingly not receiving the care they need
By Harriet Marsden, The Week UK Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
How happy is Finland really?
Today's Big Question Nordic nation tops global happiness survey for seventh year in a row with 'focus on contentment over joy'
By Harriet Marsden, The Week UK Published
-
How Tehran became the world's nose job capital
Under the radar Iranian doctors raise alarm over low costs, weak regulation and online influence of 'Western beauty standards'
By Harriet Marsden, The Week UK Published
-
Africa's renewed battle against female genital mutilation
Under the radar Campaigners call for ban in Sierra Leone after deaths of three girls as coast-to-coast convoy prepares to depart
By Harriet Marsden, The Week UK Published
-
Argentina: the therapy capital of the world
Under the radar Buenos Aires natives go hungry to pay for psychoanalysis, amid growing instability, anxiety – and societal acceptance
By Harriet Marsden, The Week UK Published
-
Does declining birth rate spell doom for Britain?
Today's Big Question Ageing population puts pressure on welfare state, economy and fabric of society, while fertility is rising on populist agendas
By Harriet Marsden, The Week UK Published
-
How a new blood test could revolutionise sepsis diagnosis
The Explainer Early results from ongoing trial suggest faster identification of deadly condition is possible
By The Week Staff Published